1. Company profile

Shaanxi Sun Siyi High -tech Pharmaceutical Co., Ltd. is the top 100 Chinese pharmaceutical companies in May 2017、Fortune 500 Chinese private enterprises -Amended Pharmaceutical Group Co., Ltd. and Shaanxi Provincial Pharmaceutical Leading Enterprise — Shaanxi Pharmaceutical Holding Group Co., Ltd.，Settled at No. 8, Ping An Road, Technology Development Zone, Xianyang High -tech Industrial Development Zone，Based on a family dedicated to Chinese medicine and chemical agents，Pioneering Preparation、Import and My stake betting appexport stake sports betting appof Chinese medicinal materials、High -end biopharmaceutical three -driving carriage as the core，Drugs and Food Homerious Products and Traditional Chinese Medicine Health Services "is two wings，Create the most influential big Northwest Medicine benchmarking enterprise in the future。

2. Construction scale and completion of construction

The company's total investment of 5 billion yuan，Registered funds 300 million yuan，Total area of ​​440 acres，Total construction area is about 200,000 m2，It has been built in two phases;

The first phase has completed the investment of about 1.7 billion yuan，Occupy 264 acres，Project land plot ratio is greater than 1，In line with Guotu Fa (2004) No. 232 Industrial Project Construction Land Control indicators (trial)，Indicators of medical manufacturing ≥0.6，The workshop of Chinese medicine drinking tablets has been built、Extract workshop、Comprehensive preparation workshop、Chinese Medicine Material Library、Bag Library、Products Library、Quality Inspection Center、Comprehensive office building、Logistics A library、A total of 22 buildings such as logistics B library and related auxiliary facilities，The total total building area has been completed with a total area of ​​120,000 m2，Now it has the stake betting appscale stake sports betting appof commercial mass production，It can achieve 10,000 tons/year of Chinese medicinal materials and Chinese medicine tablets，Tablet 50,000000000 tablets/year; hard container 30,0000000,000 grains/year; granular agent 50000,000 bags/year; oral solution 100000000 cents/year; expected to complete the second phase of investment and construction in 2022，Complete the in -hospital preparations、Biopharmaceutical、R & D of drugs and food homologous products、Production and sales，and the increase of Sun Siyi High -tech Pharmaceuticals responsible for the delivery and sales business of more than 5,000 independent products under the Group。

2. Product introduction

The company now has a total of 144 preparation varieties and regulations for the national drug approval number; 21 Chinese medicines are 21，123 medicines，Among them: Maternal Mochu capsule、Stomach Taiping Capsules belong to the exclusive national variety，National Chinese Medicine 3 new drugs; Women's Shin Table、Preliminary Shule Film、Huoxiang Qing Stomach Capsule、Strong liver tablets belong to the national traditional Chinese medicine 9 new medicine、National Patent Products; strive to complete 2-5 varieties of Chinese medicinal materials in 2021，2021 —— 2022 The proposed division to complete stake sports betting appthe Stake Sports Bettingamendment of the 200 Chinese medicine preparations in the Pharmaceutical Group is transferred to the production and sales of Sun Siyi High-tech Pharmaceuticals; completed the varieties of internal preparations in 3-5 traditional Chinese medicine hospitals and the provincial three hospitals The production and sales of the internal preparation project，In 2021, it is intended to complete the completion and cooperation of clinical clinical clinical and cooperation and product production and listing preparation of clinical biological preparations of new categories of new drugs.。

3, operation status

In August 2020, the company successfully passed the first GMP compliance check in Shaanxi Province、Change of the production address、Restore the production process verification of the three united on -site inspections,September has been synchronized with the EIA Acceptance to gradually commercialize mass production，December 28 has passed the EIA Experience Acceptance，In January 2021, it began to achieve listing and sales，Quickly promote the high -speed growth and high -quality sustainable development of enterprises，It is estimated that sales revenue can be achieved in 3-5 years.，Profit taxes of more than 1.5 billion，Can arrange more than 2,000 employees，Have good stake online sports bettingeconomic and social benefits。

2017 was listed as a key pharmaceutical industry project in Shaanxi Province，Enterprises always adhere to the direction of future development and the way forward.、Study forward、Platform cooperation，Win -win sharing "，Jointly matched the "Fourteenth Five -Year Plan" of the motherland。